Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab Treatment

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Study on ophthalmological comorbidities and the underlying pathomechanisms of conjunctivitis during dupilumab treatment in atopic dermatitis (AD) patients. Patients participate in the Bioday Registry.
Epistemonikos ID: ddd1399ccd70a029537963aa38a2390c9f58a2bb
First added on: May 07, 2024